General Information of the Compound
Compound ID |
CP0035875
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2,4 PDCA
Show/Hide
|
||||||||||||||||||
Synonyms |
2,4-Lutidinic acid
2,4-PYRIDINEDICARBOXYLIC ACID
2,4-Pyridine-dicarboxylate
2,4-Pyridinedicarboxylic acid hydrate, 99+%
2,4-Pyridinedicarboxylicacid, hydrate (1:1)
2vd7
2w2i
4-carboxypicolinic acid
499-80-9
4ie0
4nrq
AC1L1V1N
AC1Q5UFW
ACMC-1BNB9
AFI29F0TVL
CHEBI:44737
EC 207-892-2
EINECS 207-892-2
GTPL8744
Lutidinic acid
MFCD00149413
MJIVRKPEXXHNJT-UHFFFAOYSA-N
MLS000078055
NSC 403248
PD2
PubChem16314
Pyridine-2,4-dicarboxylic acid
SCHEMBL72377
UNII-AFI29F0TVL
cid_10365
pyridine carboxylate, 6a
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C7H5NO4
|
||||||||||||||||||
Molecular Weight |
167.12
|
||||||||||||||||||
Canonical SMILES |
OC(=O)c1ccnc(c1)C(O)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C7H5NO4/c9-6(10)4-1-2-8-5(3-4)7(11)12/h1-3H,(H,9,10)(H,11,12)
Show/Hide
|
||||||||||||||||||
InChIKey |
MJIVRKPEXXHNJT-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
499-80-9
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02612, Egl nine homolog 1
Protein ID: PT02613, Lysine-specific demethylase 5A
Protein ID: PT01988, Prolyl hydroxylase EGLN2
Clinical Information about the Compound